ArticleJournal of neurology2024

Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series.

Simone Guerrieri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.